Valuation: OssDsign AB (publ)

Market Cap 455M 47.51M 41.29M 37.94M 35.34M 67.01M 4.52B 67.96M 177M 2.21B 178M 174M 7.67B P/E 2026 *
-8.81x
P/E 2027 * -12.6x
Enterprise Value 338M 35.28M 30.66M 28.18M 26.24M 49.77M 3.36B 50.47M 131M 1.64B 132M 130M 5.69B EV / Sales 2026 *
2.02x
EV / Sales 2027 * 1.64x
Free-Float
67.17%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 2025-12-31
Director of Finance/CFO 63 2019-12-31
Chief Tech/Sci/R&D Officer 47 2021-12-31
Director TitleAgeSince
Chairman 66 2016-04-19
Director/Board Member 60 2021-12-31
Director/Board Member 61 2024-06-24
Change 5-day change 1-year change 3-year change Capi.($)
-36.11%-.--% - - 47.14M
+4.20%-1.85%-17.39%+9.58% 125B
+0.04%-1.01%+1.39%-6.08% 12.77B
+7.83%+2.71%+43.32%+112.86% 8.71B
+2.29%+7.17%-46.92%-72.29% 4.07B
+4.16%+8.39%+25.37%+43.89% 2.73B
+2.53%+23.07%-7.66%-13.04% 1.89B
+3.55%+8.85%-0.99%-23.29% 1.67B
-5.25%-5.89%+179.33%+133.76% 1.46B
Average -1.86%+1.23%+22.06%+23.17% 19.81B
Weighted average by Cap. +3.89%+2.90%-10.46%+13.01%

Financials

2026 *2027 *
Net sales 168M 17.51M 15.21M 13.98M 13.02M 24.69M 1.67B 25.04M 65.23M 815M 65.68M 64.27M 2.83B 238M 24.9M 21.64M 19.89M 18.52M 35.13M 2.37B 35.62M 92.8M 1.16B 93.44M 91.43M 4.02B
Net income -51.27M -5.36M -4.66M -4.28M -3.98M -7.56M -510M -7.66M -19.96M -249M -20.1M -19.67M -865M -35.73M -3.73M -3.24M -2.98M -2.78M -5.27M -355M -5.34M -13.91M -174M -14.01M -13.71M -603M
Net Debt -117M -12.23M -10.62M -9.76M -9.09M -17.24M -1.16B -17.49M -45.56M -569M -45.87M -44.88M -1.97B -63M -6.58M -5.72M -5.26M -4.9M -9.29M -626M -9.42M -24.53M -306M -24.7M -24.17M -1.06B
Logo OssDsign AB (publ)
OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The Company uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The Company's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
Employees
35
Trader
Investor
-
Global
-
Quality
ESG MSCI
-